Genetic Testing for Families at Risk of Cancer

Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer

Recruiting Observational Study
Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
1,500 (estimated)
Sponsor
Memorial Sloan Kettering Cancer Center · Other
Who this trial is looking for

This trial is looking for adults and children who may have a genetic risk for cancer. Participants will be involved in research to help identify genetic changes that could lead to earlier cancer detection or reduced cancer risk.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have had genetic testing to check for genetic variants.
  • I have a personal history of cancer or precancerous conditions.
  • I have early-onset cancer or multiple cancers in my family.
  • I have a family history suggestive of genetic cancer risk.
  • I am a family member of someone already in the study.
  • I can provide informed consent or have parental consent if I am a child.

You may not be able to join if

  • I have a condition that affects my ability to give consent.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This study is being done to attempt to identify genetic mutations or other gene-based variations in adults and children who have cancer, or are likely to develop an inherited form of cancer, and potentially reduce their risk for cancer or treat the cancer earlier.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Individuals who have undergone clinical and/or research genetic evaluation, found to have or not have a germline genetic variant (pathogenic, likely pathogenic, variant of uncertain/unknown significance, likely benign). * Individuals with or without a personal history of malig…
Contacts

Kenneth Offit, MD, MPH

646-888-4059

offitk@mskcc.org

CONTACT

Mark Robson, MD

646-888-5486

robsonm@mskcc.org

CONTACT